92 related articles for article (PubMed ID: 8565737)
1. [The expression and significance of proliferating cell nuclear antigen/cyclin in cholangiocarcinoma and gallbladder carcinoma].
Yang Z; Zhong D; Li Y
Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):437-8. PubMed ID: 8565737
[TBL] [Abstract][Full Text] [Related]
2. [The expressions of proliferating cell nuclear antigen (PCNA) in primary gallbladder carcinoma and its significance].
Qing D; Xia L; Zhang X
Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):102-4. PubMed ID: 7656696
[TBL] [Abstract][Full Text] [Related]
3. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue.
Harada K; Shimoda S; Kimura Y; Sato Y; Ikeda H; Igarashi S; Ren XS; Sato H; Nakanuma Y
Hepatology; 2012 Jul; 56(1):157-64. PubMed ID: 22290731
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of extrahepatic bile ducts and gallbladder metastatic to the ovary: a report of 16 cases.
Khunamornpong S; Lerwill MF; Siriaunkgul S; Suprasert P; Pojchamarnwiputh S; Chiangmai WN; Young RH
Int J Gynecol Pathol; 2008 Jul; 27(3):366-79. PubMed ID: 18580314
[TBL] [Abstract][Full Text] [Related]
5. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
Li N
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
[TBL] [Abstract][Full Text] [Related]
6. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
7. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
[TBL] [Abstract][Full Text] [Related]
9. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
Shrestha ML; Miyake H; Kikutsuji T; Tashiro S
J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
[TBL] [Abstract][Full Text] [Related]
13. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma.
Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y
Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640
[TBL] [Abstract][Full Text] [Related]
14. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
[TBL] [Abstract][Full Text] [Related]
15. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
Zheng J; Zhu YM
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
[TBL] [Abstract][Full Text] [Related]
18. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer].
Sakurai K; Hata S; Amano S; Kimura T; Hori A; Sakamoto A; Kimizuka K; Mimatsu K; Nishio S; Miyake H; Shibata M; Fukuzawa M
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1269-72. PubMed ID: 9703805
[TBL] [Abstract][Full Text] [Related]
20. Correlation of proliferating cell nuclear antigen expression with the clinical and biological characteristics and prognosis of hypopharyngeal carcinoma.
Yao LS; Li XP; Li Q; Zhang JH
Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):448-50. PubMed ID: 12390713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
